Literature DB >> 12358952

Coagulation effects of in vitro serial haemodilution with a balanced electrolyte hetastarch solution compared with a saline-based hetastarch solution and lactated Ringer's solution.

A M Roche1, M F M James, M P W Grocott, M G Mythen.   

Abstract

The hydroxyethyl starches are a group of compounds that has been associated with impairment of coagulation when large volumes are administered. The thrombelastograph is commonly used to assess point-of-care whole blood coagulation. Little is known about the dose-response relationships of haemodilution, and it is reasonable to assume that a linear association exists. This may not be the case with altered electrolyte compositions of the fluids used for haemodilution. We have therefore conducted an in vitro study of haemodilution of human whole blood using lactated Ringer's solution and two high molecular weight hetastarches, one in a balanced salt solution, the other in a 0.9% saline solution. The thrombelastograph, commonly used for the assessment of the coagulation effects of synthetic colloids, was used as the coagulation assessment device. Serial haemodilution with hetastarch in a balanced salt solution demonstrated a biphasic response (of r-times and k-times, as well as alpha angles), with haemodilution in the 20-40% range causing enhanced coagulation, and higher degrees of dilution causing a decrease in overall coagulation performance. A similar picture was observed with lactated Ringer's solution, but only significantly so in alpha angles. Hetastarch in saline did not display this initial increased coagulability at mild to moderate dilutions. This biphasic response of lactated Ringer's solution and hetastarch in a balanced salt solution reflects the complex interaction of fluids and the coagulation system, and that these effects cannot be attributed to simple haemodilution. On the other hand, there was a linear decrease in maximum amplitude with haemodilution. Maximum amplitude was particularly affected by both starches, which is an expected finding in view of the known interaction between the hydroxyethyl starches and von Willebrand's factor.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12358952     DOI: 10.1046/j.1365-2044.2002.02707.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  7 in total

1.  The effects of commonly used resuscitation fluids on whole blood coagulation.

Authors:  T J Coats; E Brazil; M Heron
Journal:  Emerg Med J       Date:  2006-07       Impact factor: 2.740

2.  Does calcium cause the different effects of Gelofusine and Haemaccel on coagulation?

Authors:  T J Coats; M Heron
Journal:  Emerg Med J       Date:  2006-03       Impact factor: 2.740

Review 3.  Bench-to-bedside review: Chloride in critical illness.

Authors:  Nor'azim Mohd Yunos; Rinaldo Bellomo; David Story; John Kellum
Journal:  Crit Care       Date:  2010-07-08       Impact factor: 9.097

4.  The effect of hyperglycemia on blood coagulation: In vitro, observational healthy-volunteer study using rotational thromboelastometry (ROTEM).

Authors:  Hyun-Jung Shin; Hyo-Seok Na; Soowon Lee; Gwan-Woo Lee; Sang-Hwan Do
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

Review 5.  Intravenous Fluid Administration and the Coagulation System.

Authors:  Corrin J Boyd; Benjamin M Brainard; Lisa Smart
Journal:  Front Vet Sci       Date:  2021-04-15

6.  Balanced versus chloride-rich solutions for fluid resuscitation in brain-injured patients: a randomised double-blind pilot study.

Authors:  Antoine Roquilly; Olivier Loutrel; Raphael Cinotti; Elise Rosenczweig; Laurent Flet; Pierre Joachim Mahe; Romain Dumont; Anne Marie Chupin; Catherine Peneau; Corinne Lejus; Yvonnick Blanloeil; Christelle Volteau; Karim Asehnoune
Journal:  Crit Care       Date:  2013-04-19       Impact factor: 9.097

7.  Thrombin-antithrombin complex measurement using a point-of-care testing device for diagnosis of disseminated intravascular coagulation in dogs.

Authors:  Kenji Rimpo; Aki Tanaka; Masayasu Ukai; Yuichi Ishikawa; Miyuki Hirabayashi; Toshihiro Shoyama
Journal:  PLoS One       Date:  2018-10-10       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.